# Identify the Benefits CAREGIVERSPRO-MMD Platform Use Based on the Information and Communications Technology, Dedicated to the Support and Assistance of Dyads Living With Neurocognitive Diseases and Their Primary Caregivers

> **NCT03536975** · NA · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 48 (actual)

## Conditions studied

- Cognitive Impairment, Mild
- Dementia, Mild

## Interventions

- **OTHER:** Platform

## Key facts

- **NCT ID:** NCT03536975
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2019-04-29
- **Final completion:** 2019-04-29
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03536975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03536975, "Identify the Benefits CAREGIVERSPRO-MMD Platform Use Based on the Information and Communications Technology, Dedicated to the Support and Assistance of Dyads Living With Neurocognitive Diseases and Their Primary Caregivers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03536975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
